129
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

ETV6::ACSL6 fusion gene in myeloid malignancies with eosinophilia: a report of two cases with t(5;12) or normal karyotype

, , , , , ORCID Icon & show all
Pages 225-229 | Received 19 Jun 2022, Accepted 13 Oct 2022, Published online: 31 Oct 2022

References

  • Haferlach C, Bacher U, Schnittger S, et al. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events. Genes Chromosomes Cancer. 2012;51(4):328–337.
  • Yagasaki F, Jinnai I, Yoshida S, et al. Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5; 12)(q31; p13). Genes Chromosom Cancer. 1999;26(3):192–202.
  • Cools J, Mentens N, Odero MD, et al. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4; 12)(q11-q12; p13) or t(5;12)(q31; p13). Blood. 2002;99(5):1776–1784.
  • Murati A, Adelaide J, Gelsi-Boyer V, et al. t(5;12)(q23-31; p13) with ETV6-ACSL6 gene fusion in polycythemia vera. Leukemia. 2006;20(6):1175–1178.
  • Katsura Y, Suzukawa K, Nanmoku T, et al. Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13). Cancer Genet Cytogenet. 2007;178(1):85–88.
  • Gosenca D, Erben P, Haferlach C, et al. Clinical and molecular heterogeneity of eosinophilia-associated myeloproliferative neoplasms with a translocation t(5;12). Blood. 2009;114(22):4983–4983.
  • Erben P, Gosenca D, Müller MC, et al. Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis. Haematologica. 2010;95(5):738–744.
  • Luca-Johnson D, Ninfea JIR, Pearson L, et al. Myeloid neoplasms with t(5; 12) and ETV6-ACSL6 gene fusion, potential mimickers of myeloid neoplasm with PDGFRB rearrangement: case report with imatinib therapy and review of the literature. Case Rep Med. 2016;2016:8324791.
  • Su RJ, Jonas BA, Welborn J, et al. Chronic eosinophilic leukemia, NOS with t(5; 12)(q31; p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Hum Pathol. 2016;5:6–9.
  • Yang Y, Lin H, Du Z, et al. Imatinib therapy in acute myeloid leukemia with DEK-NUP214 and FIP1L1-PDGFRA rearrangement: a case report. Oncol Lett. 2020;19(5):3587–3592.
  • Baldazzi C, Luatti S, Marzocchi G, et al. t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities. Cancer Genet. 2022;262–263:35–39.
  • Wu X, Cai H, Qiu Y, et al. ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes. Orphanet J Rare Dis. 2020;15(1):192.
  • Tang Z, Toruner GA, Tang G, et al. Chronic myeloid leukemia with insertion-derived BCR–ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis. Mod Pathol. 2020;33(10):2035–2045.
  • Di Paola J, Porter CC. ETV6-related thrombocytopenia and leukemia predisposition. Blood. 2019;134(8):663–667.
  • Butt NM, Lambert J, Ali S, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176(4):553–572.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.